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Figure 3 Cell viability in concentrations of benzylamine treatments of 3uM, 300nM, 30nM, 3nm compared to controls of cell 
media and a DMSO treatment. The absorbance of crystal violet-stained cells was measured at 590nm at 24, 48, 72, and 96 
hours. Each treatment average absorbance was normalized to the cell media control absorbance and. A) MCF7 cell viability. 
n=3. B) SUM159 cell viability. n=2. At 24 hours n=3.
Figure 2 A) SUM159 cells at 24 hours. Wells 
containing only media were very confluent. 
B) SUM159 cells at 72 hours. Cells flaked 
off during the crystal violet staining. We 
troubleshot by decreasing the number of 
cells seeded to 10,000 cells per well. C)
MCF7 cells at 72 hours. Treatments were 
added in replicates of 4 to randomized 
wells to normalize for different evaporation 
rates across the plate.
Figure 1 A) SUM159 cells B) MCF7 cells C) The chemical structure of the benzylamine and epoxide 
product
• Breast cancer is currently the most prevalent cancer in the 
world
• Selective estrogen receptor modulators and antibody-based 
therapies are effective against early-stage breast cancer
• Few treatment options exist for late-stage tumors lacking the 
progesterone, estrogen, and HER2 receptors (Triple Negative 
Breast Cancer)
• MCF7 breast cancer cell line represents early-stage breast 
cancer due to the presence of all three target receptors
• SUM159 breast cancer cell line is triple negative, providing a 
late-stage breast cancer model
• Hexylamine and epoxide product has cytotoxic effects against 
HL-60 human leukemia cell line (Xie and Hansen 2019)
• What are the effects of the benzylamine and epoxide product 
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• The benzylamine-treated MCF7 cells had decreased 
cell viability compared to cells treated with DMSO
• The benzylamine-treated SUM159 cells had decreased 
cell viability compared to cells treated with DMSO
• Continue repeating the current protocol in order to further 
confirm trends of decreased cell viability in benzylamine-
treated cells
• Investigate the effects of the benzylamine product on 
normal human cells to ensure that benzylamine doesn’t 
have cytotoxic effects on non-cancerous cells
• Confirm that benzylamine-treated cells are undergoing 
apoptosis via flow cytometry.
• Investigate the effect of benzylamine on prostate cancer cell 
lines
• Determine the cellular mechanisms or pathways involved in 
the cytotoxic effects of benzylamine
• Investigate potential co-treatment of benzylamine and 
vitamin D in breast cancer cells
• Treat MCF7 and SUM159 with other epoxide products 
synthesized in Dr. Jeff Hansen’s organic chemistry lab
Xie, M., Hansen, J. (2019). A Diversity-Oriented Synthesis 
Approach to Drug Discovery: β-Amino Alcohols [Unpublished 
bachelor’s thesis]. DePauw University.
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